Latest news
XENE Advances Pipeline with NDA Submission Plans Amid High Price-to-Sales Valuation - GuruFocusGuruFocus · Fri, 07 Aug 2026 03:21:23 GMTOcular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 16:00:37 GMTPalvella Reports Q2 Net Loss and Advances QTORIN NDA Plans - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:36:00 GMTHow NDA govt plans to bring Gold out of Indian households out into the market! - The StatesmanThe Statesman · Tue, 04 Aug 2026 09:30:00 GMTWeekly Recap: September 2026 seralutinib NDA and $115.9M debt cut - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTOCUL: Strong Phase 3 data for AXPAXLI drives NDA plans, but losses widen as R&D and launch costs rise - TradingViewTradingView · Mon, 03 Aug 2026 11:17:23 GMTOcular estimates AXPAXLI treatment burden up to 72% below projected aflibercept - Stock TitanStock Titan · Mon, 03 Aug 2026 11:00:00 GMTOcular Therapeutix plans NDA submission for AXP... - PluangPluang · Mon, 03 Aug 2026 07:00:00 GMT